Prevention of aromatase inhibitor–induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s00198-023-06683-0.pdf
Reference26 articles.
1. Qian X, Li Z, Ruan G et al (2020) Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials. Breast Cancer Res Treat 179:275–285. https://doi.org/10.1007/s10549-019-05464-w
2. Park J-H, Anderson WF, Gail MH (2015) Improvements in US breast cancer survival and proportion explained by tumor size and estrogen-receptor status. J Clin Oncol Off J Am Soc Clin Oncol 33:2870–2876. https://doi.org/10.1200/JCO.2014.59.9191
3. Kyvernitakis I, Albert U-S, Kalder M et al (2015) Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer. Climacteric J Int Menopause Soc 18:63–68. https://doi.org/10.3109/13697137.2014.929105
4. Brufsky AM, Harker WG, Beck JT et al (2012) Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole. Cancer 118:1192–1201. https://doi.org/10.1002/cncr.26313
5. Gnant M, Pfeiler G, Dubsky PC et al (2015) Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Lond Engl 386:433–443. https://doi.org/10.1016/S0140-6736(15)60995-3
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of ROCK1 as a novel biomarker for postmenopausal osteoporosis and pan-cancer analysis;Aging;2023-09-07
2. The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy;Frontiers in Oncology;2023-07-07
3. Zoledronic-acid;Reactions Weekly;2023-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3